Source: ERJ Open Res, 7 (1) 00772-2020; 10.1183/23120541.00772-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bashar N. Alzghoul, Mohammad As Sayaideh, Brian F. Moreno, Saminder K. Singh, Ayoub Innabi, Raju Reddy, Eric S. Papierniak, Hassan M Alnuaimat. Pulmonary hypertension in eosinophilic versus noneosinophilic COPD. ERJ Open Res, 7 (1) 00772-2020; 10.1183/23120541.00772-2020

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension at the patients with bronchial asthma and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 58s Year: 2004 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Pulmonary vascular remodelling in COPD versus bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Systemic inflammation and pulmonary hypertension in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Bronchial vascularity in the airways of chronic bronchitis and COPD smokers Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Source: Eur Respir J 2007; 29: 906-913 Year: 2007 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma Source: Eur Respir J 2009; 34: 1489-1492 Year: 2009 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Clinical physiology Year: 2006 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Bronchial hyperresponsiveness in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003